Ligand Pharmaceuticals Incorporated

NASDAQ: LGND
Share price (8/12/25): $152.69
Market cap (8/12/25): $2.992 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Business combination disclosure

Automatic shelf registration

Business combination disclosure

Ownership Filter

Kozarich John W

Kozarich John W

Kozarich John W

Kozarich John W

News Filter

Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

Reports Second Quarter 2025 Financial Results and Raises Guidance

Announces Completion of Pelthos Therapeutics Merger With Channel Therapeutics

Shareholder Vote Results

Reports First Quarter 2025 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Scanned paper annual report submission

Letter from the SEC